A rigorous review and analysis of the medical literature determined that weight loss by means of diet and lifestyle interventions reduces the severity of psoriasis in overweight or obese patients (Upala 2015)
GHR Distinction While both peptides facilitate healing, they pull different molecular levers
GLOW is a powerful peptide injection therapy that combines: BPC-157 (5mg) a gastric-derived peptide that promotes tissue healing TB-500 (10mg) a synthetic form of thymosin beta-4 that regulates inflammation and cellular repair GHK-Cu (27mg) a copper-binding peptide that stimulates collagen, elastin, and wound healing This unique combination delivers full-spectrum regenerative support, from the inside outtargeting muscle, tendon, skin, fascia, and even blood vessels
Bjrnson and colleagues estimated that Lp(a) is substantially more atherogenic than LDL on a per-particle basis, with an estimated 6.6-fold greater atherogenicity than LDL (Bjrnson et al., 2024)
Patients administered with CagriSema resulted in greater weight loss at 68 weeks, reaching 22.7% versus 2.3% in the placebo group during evaluation of the treatment effect if all patients stayed on treatment
3 multiple-use glass vials 10mL each
